Holen Sie sich die Stockscreener-App
8.30
1.07%
-0.09
Handel nachbörslich:
8.30
Schlusskurs vom Vortag:
$8.39
Offen:
$8.36
24-Stunden-Volumen:
886.35K
Relative Volume:
0.72
Marktkapitalisierung:
$442.81M
Einnahmen:
$1.02B
Nettoeinkommen (Verlust:
$-757.20M
KGV:
-0.5623
EPS:
-14.76
Netto-Cashflow:
$-257.90M
1W Leistung:
-10.08%
1M Leistung:
+27.69%
6M Leistung:
+17.56%
1J Leistung:
-6.85%
1-Tages-Spanne:
$8.1617
$8.4001
1-Wochen-Bereich:
$8.1617
$9.267
52-Wochen-Spanne:
$4.02
$12.73
Emergent Biosolutions Inc Stock (EBS) Company Profile
Firmenname
Emergent Biosolutions Inc
Sektor
Telefon
240-631-3200
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Vergleichen Sie EBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
8.30 | 447.62M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
156.40 | 68.60B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 47.28B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 43.41B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.38 | 20.69B | 16.70B | -157.13M | 1.19B | -0.155 |
|
NBIX
Neurocrine Biosciences Inc
|
139.60 | 13.78B | 2.41B | 305.80M | 492.20M | 2.95 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-07 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Underweight |
| 2023-08-29 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-04-10 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-04-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-11-08 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-05-05 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Eingeleitet | The Benchmark Company | Buy |
| 2021-02-24 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | Fortgesetzt | JP Morgan | Neutral |
| 2020-07-31 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-09-04 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | Hochstufung | Goldman | Neutral → Buy |
| 2018-08-03 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-06-13 | Eingeleitet | Argus | Buy |
| 2018-04-25 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2018-01-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | Singular Research | Buy |
| 2016-04-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2016-03-28 | Eingeleitet | Singular Research | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2014-05-15 | Eingeleitet | Summer Street Research | Buy |
| 2011-05-31 | Bestätigt | WBB Securities | Strong Buy |
| 2011-01-10 | Bestätigt | Wedbush | Outperform |
| 2010-11-05 | Bestätigt | Wedbush | Outperform |
| 2010-08-18 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | Bestätigt | Caris & Company | Buy |
Alle ansehen
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Custom watchlist performance reports with Emergent BioSolutions Inc.Market Growth Review & High Accuracy Buy Signal Tips - Newser
Statistical indicators supporting Emergent BioSolutions Inc.’s strengthJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
Is Emergent BioSolutions Inc. meeting your algorithmic filter criteria2025 Market Trends & Daily Oversold Bounce Ideas - Newser
Can trapped investors hope for a rebound in Emergent BioSolutions Inc.Market Activity Report & Real-Time Volume Spike Alerts - Newser
How moving averages guide Emergent BioSolutions Inc. trading2025 Price Targets & Weekly High Return Stock Opportunities - Newser
Tools to monitor Emergent BioSolutions Inc. recovery probabilityWeekly Trend Recap & Long-Term Safe Investment Plans - Newser
Real time breakdown of Emergent BioSolutions Inc. stock performanceTrade Entry Report & Safe Capital Growth Plans - Newser
Volume spikes in Emergent BioSolutions Inc. stock – what they meanQuarterly Performance Summary & Verified Stock Trade Ideas - Newser
Applying sector rotation models to Emergent BioSolutions Inc.CPI Data & Daily Oversold Bounce Ideas - Newser
Emergent BioSolutions Inc. stock trend outlook and recovery pathShort Setup & AI Enhanced Trade Execution Alerts - Newser
Can Emergent BioSolutions Inc. hit a new high this monthPortfolio Gains Report & Community Driven Trade Alerts - Newser
Can a trend reversal in Emergent BioSolutions Inc. lead to recoveryEarnings Growth Summary & Safe Entry Trade Signal Reports - Newser
Building trade automation scripts for Emergent BioSolutions Inc.July 2025 Gainers & Weekly Sector Rotation Insights - Newser
Is now a turning point for Emergent BioSolutions Inc.Global Markets & Weekly Stock Breakout Alerts - Newser
Can swing trading help recover from Emergent BioSolutions Inc. lossesPortfolio Gains Summary & Reliable Price Breakout Alerts - Newser
Published on: 2025-08-30 01:48:18 - Newser
Why Emergent BioSolutions Inc. stock attracts strong analyst attention2025 Stock Rankings & Expert Curated Trade Ideas - Newser
Using data models to predict Emergent BioSolutions Inc. stock movementQuarterly Trade Summary & Consistent Profit Trading Strategies - Newser
Is Emergent BioSolutions Inc. stock bottoming outProfit Target & Free Growth Oriented Trading Recommendations - Newser
Published on: 2025-08-29 23:22:17 - Newser
Will Emergent BioSolutions Inc. stock recover after recent dropTake Profit & Weekly Watchlist of Top Performers - Newser
Heatmap analysis for Emergent BioSolutions Inc. and competitorsWeekly Trend Report & Consistent Income Trade Ideas - Newser
Published on: 2025-08-29 17:23:28 - Newser
How Interest Rate Changes Impact Emergent BioSolutions Inc. Stock Performance2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
How Emergent BioSolutions Inc. stock performs during market volatilityTrade Risk Report & Community Consensus Stock Picks - Newser
Has Emergent BioSolutions Inc. found a price floorJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
Detecting price anomalies in Emergent BioSolutions Inc. with AIJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser
Sector ETF performance correlation with Emergent BioSolutions Inc.New Guidance & AI Powered Market Trend Analysis - Newser
How to escape a deep drawdown in Emergent BioSolutions Inc.Weekly Profit Summary & Consistent Return Investment Signals - Newser
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day - The Manila Times
Emergent BioSolutions and the Opioid Crisis: A Strategic Opportunity in Public Health Innovation - AInvest
Emergent BioSolutions Partners with Emmitt Smith and Zac Clark to Launch Opioid Education Campaign on College Campuses - Quiver Quantitative
Emergent BioSolutions Launches College Naloxone Education Campaign | EBS Stock News - Stock Titan
Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):